Discovery and Non-Clinical Biomarkers

Discovery and non-clinical biomarker solutions

OHMX.bio offers comprehensive discovery and non-clinical biomarker services, designed to support early-phase research with the broadest possible range of screening and detection technologies. Whether you need genomic, proteomic, or transcriptomic insights, OHMX.bio’s extensive capabilities and scientific expertise ensure that you have the data and analysis necessary to identify meaningful biomarker candidates.

Sequencing for broad biomarker discovery

OHMX.bio’s next-generation sequencing (NGS) platform is ideal for large-scale biomarker discovery efforts. NGS enables high-throughput screening of genomic, transcriptomic, and epigenomic changes across a wide variety of sample types. OHMX.bio’s sequencing services include:

Genomic Screening

Identify genetic mutations, single nucleotide polymorphisms (SNPs), and copy number variations (CNVs) with high sensitivity.

Gene Expression Profiling

Analyze differential expression to discover novel transcriptomic biomarkers.

Epigenomic Insights

Detect methylation patterns or RNA modifications that may contribute to biomarker signatures.

Sequencing provides an ideal starting point for biomarker discovery, offering a comprehensive and unbiased view of potential targets.
OHMX.bio - Innovative omics solutions
OHMX.bio_Innovative omics solutions_Scientific Excellence

Proteomic biomarker solutions

OHMX.bio’s proteomic services provide powerful tools for the discovery of protein biomarkers through both mass spectrometry (MS) and sequencing-based targeted proteomics.

Mass Spectrometry-Based Proteomics

Identify and quantify protein biomarkers, including post-translational modifications and metabolites, using high-resolution MS technology. This approach is ideal for broad protein biomarker discovery and deep proteomic profiling.

Sequencing-Based Targeted Proteomics

For more focused discovery or validation efforts, OHMX.bio offers targeted proteomics using sequencing platforms. This high-throughput approach enables accurate quantification of specific protein targets with high sensitivity.

Proteomic biomarkers offer unique insights into functional changes at the protein level, complementing sequencing data for more comprehensive biomarker discovery.

qPCR biomarker capabilities

OHMX.bio’s qPCR services provide another powerful option for targeted biomarker discovery and validation. qPCR is ideal for researchers seeking to:

Use Commercial Kits

OHMX.bio can run standardized assays for popular biomarker targets using validated commercial kits.

Design Custom Primers

For unique or novel targets, OHMX.bio can design primers tailored to your specific gene or sequence of interest.

OHMX.bio adheres to MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) guidelines, ensuring high-quality, reproducible, and transparent qPCR results. qPCR offers rapid, high-throughput, and cost-effective biomarker screening, making it a versatile tool for non-clinical discovery research.
OHMX.bio_Innovative omics solutions

Seamless transition to clinical phases

OHMX.bio’s expertise is not limited to discovery. With extensive experience in clinical-phase research, OHMX.bio ensures that biomarkers identified in the discovery phase can be validated and carried forward into clinical trials. This seamless transition guarantees continuity and quality across all research phases, accelerating your path to clinical implementation.
OHMX.bio_Innovative omics solutions_Tailored Personal Approach

Comprehensive bioinformatics support

OHMX.bio provides advanced bioinformatics expertise to support biomarker discovery and analysis. Custom bioinformatics pipelines can be tailored to:

Data Integration and Analysis

Comprehensive analysis of genomic, transcriptomic, and proteomic data to identify meaningful biomarkers.

Visualization and Reporting

High-quality, publication-ready data visualizations and customizable reports for deeper insights.

OHMX.bio’s bioinformatics team ensures that all data is processed with accuracy, reproducibility, and scientific rigor, providing actionable insights for even the most complex biomarker discovery projects.

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!
Our experts will reply within 2 working days to freely discuss your omics project.

Our publications using discovery and non-clinical biomarker solutions

  1.